Hypergastrinemia in INS-GAS mice leads to accelerated
carcinogenesis of the stomach, but the mechanisms have not been well defined. We investigated the possible role of
gastrin-induced gastric cell apoptosis in the development of
gastric cancer. We examined apoptosis and the expression of Bcl-2 family
proteins in INS-GAS mice of different ages, as well as in
gastrin-deficient (GAS-KO) mice after
gastrin-17 (G-17) infusion. In addition, we studied the effects of the
gastrin/
cholecystokinin-2 (CCK-2) receptor antagonist
YF476 and/or
histamine H2 (H-2) receptor antagonist
loxtidine on apoptosis and
atrophy in INS-GAS mice with or without Helicobacter felis (H. felis)
infection. INS-GAS mice had age-associated increases in
Bax protein expression and decreases in Bcl-2
protein expression, along with increased glandular and epithelial cell apoptosis. At 8-week
gastrin infusions in GAS-KO mice resulted in a similar pattern of altered Bax and Bcl-2 expression, followed by gastric cell apoptosis. H. felis
infection of INS-GAS mice led to increased apoptosis and the development of
atrophy, whereas treatment with either
YF476 and/or
loxtidine strongly inhibited both apoptosis and
atrophy. In vitro studies with Fas-expressing RGM1 cells showed that
gastrin stimulation alone directly induced apoptosis via
gastrin/CCK-2 receptor and synergized with FasL stimulation. These results indicate that
gastrin can induce apoptosis in gastric epithelial cells and contribute to the development of gastric
carcinogenesis.